|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s81A1DD70-5A98-11EF-AB18-1A9385CE164B&I=39IZM&T=&OP=Display&O=html&O1=15146489&O2=954925415942&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DDiscovery%2520of%252012%2520%2528BMS-986172%2529%2520as%2520a%2520Highly%2520Potent%2520MGAT2%2520Inhibitor%2520that%2520Achieved%2520Targeted%2520Efficacious%2520Exposures%2520at%2520a%2520Low%2520Human%2520Dose%2520for%2520the%2520Treatment%2520of%2520Metabolic%2520Disorders%26rft.au%3DBrigance%252C%2520Robert%26rft.au%3DMeng%252C%2520Wei%26rft.au%3DMignone%252C%2520James%26rft.au%3DNegash%252C%2520Lidet%26rft.date%3D2023-09-28%26rft.eissn%3D1520-4804%26rft.epage%3D13147%26rft.externalDocID%3Da415061855%26rft.genre%3Darticle%26rft.issn%3D0022-2623%26rft.issue%3D18%26rft.jtitle%3DJournal%2520of%2520medicinal%2520chemistry%26rft.pub%3DAmerican%2520Chemical%2520Society%26rft.spage%3D13135%26rft.volume%3D66%26rft_id%3Dinfo%253Adoi%252F10.1021%252Facs.jmedchem.3c01147%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_IJS_KILJ_LCL-getFullTxt-object,2-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_PNG_LCL-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,6-NCBI_PUBMED_FREE-getAbstract-object,7-ISI_WEB_OF_SCIENCE-getAuthor-object,8-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,9-REFWORKS_EXPORT_TOOL-getReference-object,10-SHERPA_RoMEO_LCL-getWebService-object,11-GOOGLE_SCHOLAR_FREE-getWebSearch-object,12-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.832714&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15146489-s81A1DD70-5A98-11EF-AB18-1A9385CE164B" timestamp="2024-08-15T01:54:14Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925415942</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Discovery of12(BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders</jnl:atitle>
<jnl:jtitle>Journal of Medicinal Chemistry</jnl:jtitle>
<jnl:date>2023-09-28</jnl:date>
<jnl:spage>13135</jnl:spage>
<jnl:epage>13147</jnl:epage>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:issn>0022-2623</jnl:issn>
<jnl:volume>66</jnl:volume>
<jnl:issue>18</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1520-4804</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:cd8f11159c306f22f2af829dd42db96b012f27ac</ctx:identifier>
<ctx:identifier>urn:UUID:s81A1DD70-5A98-11EF-AB18-1A9385CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)